Finance

Lists
HCA:NYSE
HCA Healthcare Inc
$ 458.60
+1.66%
(+7.51) 1D
$ 458.60
0.00% (0.00)
After hours
Closed: 10-р сарын 12, 16:00:04 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCA...
Open
$ 450.58
High
$ 460.28
Low
$ 444.81
Mkt. cap
99.29 тэрбум
Avg. vol.
1.38 сая
Volume
0.00
Dividend
0.68%
Quarterly dividend
$ 0.78
Ex-dividend date
2026 оны 9-р сарын 16
P/E ratio
15.35
52-wk high
$ 556.52
52-wk low
$ 353.99
EPS
$ 29.87
Beta
1.11
Shares outstanding
216.50 сая
No. of employees
275 мян
Open
$ 450.58
High
$ 460.28
Low
$ 444.81
Mkt. cap
99.29 тэрбум
Avg. vol.
1.38 сая
Volume
0.00
Dividend
0.68%
Quarterly dividend
$ 0.78
Ex-dividend date
2026 оны 9-р сарын 16
P/E ratio
15.35
52-wk high
$ 556.52
52-wk low
$ 353.99
EPS
$ 29.87
Beta
1.11
Shares outstanding
216.50 сая
No. of employees
275 мян
News stories
From web sources and news partners
Profile
HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors. Wikipedia
About HCA Healthcare Inc
CEOSamuel N. Hazen
Employees275 мян
Founded1968
HeadquartersНэшвиль, Теннесси, Америкийн Нэгдсэн Улс
SectorHealth care provider
Websitehcahealthcare.com
Analyst ratings
Based on 22 analysts giving stock ratings to HCA in the past 3 months
Buy
Buy
14
Hold
7
Sell
1
12-month forecast
Based on 22 Wall Street analysts offering 12 month price targets for HCA in the last 3 months.
Highest
Current $ 458.60
$ 579.00 (+26.25%)
Average
$ 458.65 (+0.01%)
Lowest
$ 380.00 (-17.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Maintained
$ 460.00
+0.3%
10/12/2026
Ben Hendrix
RBC Capital
Buy
Maintained
$ 496.00
+8.2%
10/07/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$ 387.00
-15.6%
10/07/2026
Lance Wilkes
Bernstein
Hold
Maintained
$ 426.00
-7.1%
10/05/2026
Andrew Cooper
Raymond James
Hold
Reiterated
-
-
09/28/2026
Sean Dodge
BMO Capital
Buy
Initiated
$ 495.00
+7.9%
09/22/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
09/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
$ 450.00
-1.9%
09/17/2026
Benjamin Rossi
J.P. Morgan
Hold
Maintained
$ 425.00
-7.3%
08/24/2026
Kevin Fischbeck
Bank of America Securities
Hold
Reiterated
$ 425.00
-7.3%
08/10/2026
Unknown Analyst
Argus Research
Buy
Maintained
$ 500.00
+9%
08/07/2026
David Toung
Argus Research
Buy
Reiterated
$ 500.00
+9%
08/07/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$ 495.00
+7.9%
08/05/2026
Stephen Baxter
Wells Fargo
Hold
Reiterated
$ 381.00
-16.9%
08/03/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$ 475.00
+3.6%
07/28/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
$ 485.00
+5.8%
07/27/2026
A.J. Rice
UBS
Buy
Maintained
$ 579.00
+26.3%
07/27/2026
Pito Chickering
Deutsche Bank
Buy
Reiterated
$ 476.00
+3.8%
07/27/2026
Craig Hettenbach
Morgan Stanley
Sell
Maintained
$ 380.00
-17.1%
07/27/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$ 485.00
+5.8%
07/27/2026
Michael Ha
Robert W. Baird
Hold
Maintained
$ 393.00
-14.3%
07/27/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
$ 435.00
-5.1%
07/27/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$ 525.00
+14.5%
07/14/2026
Unknown Analyst
Stephens
Buy
Reiterated
$ 530.00
+15.6%
04/27/2026
Raj Kumar CFA
Stephens
Buy
Reiterated
$ 530.00
+15.6%
04/27/2026
Courtney Breen
Bernstein
Hold
Maintained
$ 541.00
+18%
03/30/2026
Last report
2026 оны 7-р сарын 24
Fiscal period
Q2 2026
$ 7.59 / $ 7.50
+1.23%beat
Revenue / Est. (USD)
20.23 тэрбум / 19.74 тэрбум
+2.46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
19.16 тэрбум
19.51 тэрбум
19.11 тэрбум
20.23 тэрбум
Cost of goods sold
11.15 тэрбум
11.34 тэрбум
11.14 тэрбум
11.18 тэрбум
Cost of revenue
11.15 тэрбум
11.34 тэрбум
11.14 тэрбум
11.18 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1.03 тэрбум
-
-
Operating expense
5.05 тэрбум
5.00 тэрбум
5.11 тэрбум
5.99 тэрбум
Total operating expenses
16.20 тэрбум
16.34 тэрбум
16.25 тэрбум
17.16 тэрбум
Operating income
2.96 тэрбум
3.18 тэрбум
2.86 тэрбум
3.07 тэрбум
Other non operating income
-
-
-
-
EBT including unusual items
2.42 тэрбум
2.67 тэрбум
2.29 тэрбум
2.49 тэрбум
EBT excluding unusual items
2.42 тэрбум
2.63 тэрбум
2.29 тэрбум
2.48 тэрбум
Income tax expense
515.00 сая
509.00 сая
430.00 сая
564.00 сая
Effective tax rate
21.30%
19.05%
18.80%
22.61%
Other operating expenses
4.16 тэрбум
3.06 тэрбум
4.18 тэрбум
5.04 тэрбум
Net income
1.64 тэрбум
1.88 тэрбум
1.62 тэрбум
1.70 тэрбум
Net profit margin
8.57%
9.62%
8.48%
8.40%
Earnings per share
6.96
8.01
7.15
7.59
Interest and investment income
-
-
-
-
Interest expense
-561.00 сая
-572.00 сая
-584.00 сая
-599.00 сая
Net interest expenses
-561.00 сая
-572.00 сая
-584.00 сая
-599.00 сая
Depreciation and amortization charges
889.00 сая
911.00 сая
930.00 сая
944.00 сая
EBITDA
3.85 тэрбум
4.09 тэрбум
3.79 тэрбум
4.01 тэрбум
Gain or loss from assets sale
2.00 сая
-41.00 сая
1.00 сая
-10.00 сая
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс